论文部分内容阅读
近年来日本学者发现,利用活性碳吸附抗癌药能使药物持续高浓度向局部肿瘤组织释放,具有淋巴趋向性和附着肿瘤表面等特性,且不增加毒性和副作用。实验和临床研究已取得一定的效果,并引起肿瘤化疗界的注目。现综述如下。 一、活性碳吸附抗癌药的制备 萩原明郎等自1978年始对这种新剂型进行了研究,于1983年开始试制。其基本制备方法如下:将活性碳用球磨
In recent years, Japanese scholars have discovered that the use of activated carbon for the adsorption of anticancer drugs can release sustained high concentrations of drugs to local tumor tissues, with lymphatic tropism and adherent tumor surface characteristics, without increasing toxicity and side effects. Experimental and clinical studies have achieved certain results and have attracted the attention of the cancer chemotherapy community. This is summarized below. First, the preparation of activated carbon adsorption of anticancer drugs Kasahara Ming Lang, etc. since 1978 began to study this new dosage form, began trial production in 1983. The basic preparation method is as follows: